Provided by Tiger Fintech (Singapore) Pte. Ltd.

Olema Pharmaceuticals, Inc.

4.17
+0.11002.71%
Post-market: 4.170.00000.00%19:33 EDT
Volume:942.51K
Turnover:3.88M
Market Cap:285.32M
PE:-2.14
High:4.20
Open:3.96
Low:3.89
Close:4.06
Loading ...
Feb 02, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Jan 31, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Jan 08, 2024

Major Issues Report

Form 8-K - Current report
Jan 08, 2024

Major Issues Report

Form 8-K - Current report
Jan 06, 2024

Major Issues Report

Form 8-K - Current report
Dec 29, 2023

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Dec 06, 2023

Major Issues Report

Form 8-K - Current report
Dec 06, 2023

Major Issues Report

Form 8-K - Current report
Nov 30, 2023

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Nov 28, 2023

Beneficial Ownership Change

Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
Nov 23, 2023

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Nov 23, 2023

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Nov 23, 2023

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Nov 23, 2023

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Nov 23, 2023

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Nov 22, 2023

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Nov 22, 2023

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Nov 22, 2023

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Nov 22, 2023

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Nov 22, 2023

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities